Dow Down0.02% Nasdaq Up0.07%

Cempra, Inc. (CEMP)

-NasdaqGS
13.90 0.13(0.94%) Nov 25, 4:00PM EST
CompetitorsGet Competitors for:
Direct Competitor Comparison 
CEMPCBSTPFETHRXIndustry
Market Cap:498.13M5.72B191.98B1.77B135.29M
Employees:3887377,70024158.00
Qtrly Rev Growth (yoy):5.630.16-0.021.410.18
Revenue (ttm): 14.82M1.16B50.04B2.85M11.45M
Gross Margin (ttm):N/A0.710.82N/A0.52
EBITDA (ttm):-59.22M203.55M21.32B-174.93M-9.48M
Operating Margin (ttm): -4.000.100.32-63.65-1.15
Net Income (ttm):-61.58M65.08M10.46B-206.57MN/A
EPS (ttm):-1.850.861.62-1.83-0.24
P/E (ttm):N/A87.3718.80N/A28.56
PEG (5 yr expected):N/A3.2017.580.060.04
P/S (ttm):33.304.903.80614.8713.86
 
CBST = Cubist Pharmaceuticals Inc.
PFE = Pfizer Inc.
THRX = Theravance Inc.
Industry = Biotechnology

Biotechnology Companies Ranked By Sales 
CompanySymbolPriceChangeMarket CapP/E
Amgen Inc.AMGN162.24-0.01123.41B25.54
Genentech, Inc.Private - View Profile
Biogen Idec Inc.BIIB305.40-0.0072.12B28.92
Genzyme CorporationPrivate - View Profile
Merck Serono S.A.Private - View Profile
Gilead Sciences Inc.GILD101.110.01152.54B18.01
MedImmune, L.L.C.Private - View Profile
Life Technologies CorporationPrivate - View Profile
Teva Pharmaceutical Industries LimitedTEVA56.58-0.0148.36B17.60
Sandoz International GmbHPrivate - View Profile
 
View Biotechnology Industry Center

Generic Drugmakers Ranked by Sales 
CompanySymbolPriceChangeMarket CapP/E
Actavis plcACT270.310.0171.65BN/A
Ranbaxy Laboratories LimitedPrivate - View Profile
Mylan, Inc.MYL56.170.0021.02B24.32
Pfizer Inc.PFE30.470.01191.98B18.80
Johnson & JohnsonJNJ106.70-0.00298.67B17.67
GlaxoSmithKline plcGSK46.280.00111.26B17.20
SanofiSNY47.650.01125.04B24.60
Novartis AGNVS95.040.00229.87B21.84
Roche Holding AGRHHBY37.21-0.00252.84B22.89
AstraZeneca PLCAZN73.66-0.0193.03B90.27
 
View Biotechnology Industry Center

Drugmakers Ranked By Sales 
CompanySymbolPriceChangeMarket CapP/E
Abbott LaboratoriesABT44.16-0.0066.50B34.83
Bristol-Myers Squibb CompanyBMY58.52-0.0197.07B36.12
 
View Biotechnology Industry Center

 
News on Direct Competitors 

Currency in USD.